Fecal-based colorectal cancer screening among the uninsured in northern manhattan

American Journal of Preventive Medicine

Volumn 47, Issue 2, 2014, Pages 182-187

  Hillyer, Grace Clarke ^a   Schmitt, Karen M ^d   Freedberg, Daniel E ^b   Kramer, Rachel A ^f   Su, Yin ^f   Rosenberg, Richard M ^b   Neugut, Alfred I ^a,c,e  

^a Department of Medicine   (United States)

^b Division of Digestive and Liver Disease   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e Department of Medicine   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TESTING; FEMALE; GROUPS BY AGE; HEALTH EDUCATION; HISPANIC; HOUSEHOLD; HUMAN; IMMUNOCHEMISTRY; INCOME; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICALLY UNINSURED; OCCULT BLOOD; PREDICTIVE VALUE; SCREENING TEST; SEX DIFFERENCE; UNITED STATES; ADENOMA; CHEMISTRY; COLORECTAL NEOPLASMS; COMMUNITY CARE; COMPARATIVE STUDY; DIAGNOSTIC USE; EARLY DIAGNOSIS; FECES; MASS SCREENING; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

GUAIAC;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNITY HEALTH SERVICES; EARLY DETECTION OF CANCER; FECES; FEMALE; GUAIAC; HUMANS; MALE; MASS SCREENING; MEDICALLY UNINSURED; MIDDLE AGED; NEW YORK CITY; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84904705927     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.03.011     Document Type: Article

References (35)

1. Cancer screening, U.S., 2010 MMWR Morb Mortal Wkly Rep 61 3 2012 41 45
2. Community Health Survey, 2009. Colon Cancer (Timely Colonoscopy), 2009 (Age-Adjusted). nyc.gov/health/epiquery.
3. CDC Vital signs: colorectal cancer screening among adults aged 50-75 years - U.S, 2008 MMWR Morb Mortal Wkly Rep 59 26 2010 808 812
4. CDC Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - U.S., 2004-2006 MMWR Morb Mortal Wkly Rep 59 9 2010 1 25
5. U.S. Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement 2008 Agency for Healthcare Research and Quality Rockville MD AHRQ Publication No. 08-05124-EF-3
6. M. Parekh, A.M. Fendrick, and U. Ladabaum As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia Aliment Pharmacol Ther 27 8 2008 697 712
7. S.R. Cole, G.P. Young, A. Esterman, B. Cadd, and J. Morcom A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer J Med Screen 10 3 2003 117 122
8. A. Federici, P.G. Rossi, P. Borgia, F. Bartolozzi, S. Farchi, and G. Gausticchi The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial J Med Screen 12 2 2005 83 88
9. L. Hol, M.E. van Leerdam, and M. van Ballegooijen et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 1 2010 62 68
10. J.E. Allison, L.C. Sakoda, and T.R. Levin et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics J Natl Cancer Inst 99 19 2007 1462 1470
11. L. Guittet, V. Bouvier, and N. Mariotte et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location Br J Cancer 100 8 2009 1230 1235
12. R.M. Hoffman, S. Steel, E.F. Yee, L. Massie, R.M. Schrader, and G.H. Murata Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial Prev Med 50 5-6 2010 297 299
13. Z. Levi, S. Birkenfeld, and A. Vilkin et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study Int J Cancer 128 10 2010 2415 2424
14. F.A. Oort, J.S. Terhaar Sive Droste, and R.W.M. Van Der Hulst et al. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test versus guaiac-based faecal occult blood test Aliment Pharmacol Therap 31 3 2010 432 439
15. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 1 2008 82 90
16. U.S. Census Bureau. Census 2010 Summary File 1 (SF1) and Summary File 2 (SF2). American FactFinder 2010. factfinder.census.gov.
17. G. Clarke Hillyer, C.E. Basch, K.M. Schmitt, and A.I. Neugut Feasibility and efficacy of pairing fecal immunochemical testing with mammography for increasing colorectal cancer screening among uninsured Latinas in northern Manhattan Prev Med 53 3 2011 194 198
18. D. Schillinger, J. Piette, and K. Grumbach et al. Closing the loop: physician communication with diabetic patients who have low health literacy Arch Intern Med 163 1 2003 83 90
19. J.P. Kincaid, R.P. Fishburne, R.L. Rogers, and B.S. Chissom Derivation of new readability formulas (Automated Readability Index, Fog Count, and Flesch Reading Ease Formula) for Navy enlisted personnel 1975 Naval Air Station Memphis TN
20. F. Parente, C. Boemo, and A. Ardizzoia et al. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy Endoscopy 45 1 2013 27 34
21. A.H. van Roon, S.L. Goede, and M. van Ballegooijen et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening Gut 62 3 2013 409 415
22. A.H. van Roon, J.A. Wilschut, and L. Hol et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance Clin Gastroenterol Hepatol 9 4 2011 333 339
23. L. Hol, J.A. Wilschut, and M. van Ballegooijen et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 7 2009 1103 1110
24. D.I. Park, S. Ryu, Y.H. Kim, C.K. Lee, C.S. Eun, and D.S. Han Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 9 2010 2017 2025
25. S. Garbers, K. Schmitt, A.M. Rappa, and M.A. Chiasson Functional health literacy in Spanish-speaking Latinas seeking breast cancer screening through the National Breast and Cervical Cancer Screening Program Int J Womens Health 1 2010 21 29
26. H.P. Freeman Cancer in the socioeconomically disadvantaged CA Cancer J Clin 39 5 1989 266 288
27. L. Jandorf, Y. Gutierrez, J. Lopez, J. Christie, and S. Itzkowitz Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic J Urban Health 82 2 2005 216 224
28. S. Percac-Lima, R.W. Grant, and A.R. Green et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial J Gen Intern Med 24 2 2009 211 217
29. B.S. Gerber, M.R. Stolley, A.L. Thompson, L.K. Sharp, and M.L. Fitzgibbon Mobile phone text messaging to promote healthy behaviors and weight loss maintenance: a feasibility study Health Informatics J 15 1 2009 17 25
30. S. Crotta, N. Segnan, S. Paganin, B. Dagnes, R. Rosset, and C. Senore High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test Clin Gastroenterol Hepatol 10 6 2012 633 638
31. E.A. Rohan, J.E. Boehm, A. DeGroff, R. Glover-Kudon, and J. Preissle Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field Cancer 119 15S 2013 S2870 S2883
32. L.C. Seeff, A. DeGroff, and D.A. Joseph et al. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts Cancer 119 15S 2013 S2940 S2946
33. S.R. Cole, and G.P. Young Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer Med J Aust 175 4 2001 195 198
34. B. Greenwald From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening Gastroenterol Nurs 28 2 2005 90 96
35. C.A. Richards, B.D. Kerker, and L. Thorpe et al. Increased screening colonoscopy rates and reduced racial disparities in the New York citywide campaign: an urban model Am J Gastroenterol 106 11 2011 1880 1886